1. Dear Drugs-Forum readers: We are a small non-profit that runs one of the most read drug information & addiction help websites in the world. We serve over 4 million readers per month, and have costs like all popular websites: servers, hosting, licenses and software. To protect our independence we do not run ads. We take no government funds. We run on donations which average $25. If everyone reading this would donate $5 then this fund raiser would be done in an hour. If Drugs-Forum is useful to you, take one minute to keep it online another year by donating whatever you can today. Donations are currently not sufficient to pay our bills and keep the site up. Your help is most welcome. Thank you.
  1. Beenthere2Hippie
    It is more commonly known as a party drug and horse tranquiliser, but now ketamine is going to undergo trials as to whether it can be used to treat depression. The University of New South Wales has been granted a $2.1 million grant by the National Health and Medical Research council to explore and trial the use of the drugs.

    The trial, which will begin April 2016, will take 200 patients living with depression and compare the effects of ketamine against an active placebo over the course of a month.

    "We need to properly test if we can use ketamine as a treatment over a whole course of multiple doses", said Professor Colleen Loo, who is leading the study from the University of New South Wales and the Black Dog Institute.

    Ketamine, widely recognised as a party drug due to its hallucinogenic properties, is only available in Australia for use as a prescription anaesthetic. While the drug has been shown to show good short term results for treating depression, next year’s study will look to see if it can be used as a long term aid.

    "You want to have a treatment that's going to bring you out of depression and keep you well,” Professor Loo added. “What we need to do in taking the next step is look at whether giving people repeated doses can actually lead to a longer-lasting improvement, and this will be, as far as I know, the largest trial in the world of this type, looking at this.”

    The grant serves as part of a $630 million investment package from the Australian federal government for more than 800 health and prevention of disease projects across the country.

    By Carl Anka - The Independent/Nov. 8, 2015
    Newshawk Crew

    Author Bio

    BT2H is a retired news editor and writer from the NYC area who, for health reasons, retired to a southern US state early, and where BT2H continues to write and to post drug-related news to DF.


  1. Alfa
    Very nice to see this happening. Hopefully the results of the study will be positive enough to also study the effects of MXE on depression. As this is likely to have as least the same promising results.
To make a comment simply sign up and become a member!